Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms

Ann Hematol. 2022 Mar;101(3):705-708. doi: 10.1007/s00277-021-04561-5. Epub 2021 Sep 13.

Authors

Sanyun Wu¹, Ping Luo¹, Yalan Yu¹, Bei Xiong¹, Yingying Wang¹, Xuelan Zuo²

Affiliations

¹ Department of Hematology, Zhongnan Hospital of Wuhan University, Donghu Road, No. 169, Wuhan, China.
² Department of Hematology, Zhongnan Hospital of Wuhan University, Donghu Road, No. 169, Wuhan, China. zuoxuelan2004@126.com.

PMID: 34518917
DOI: 10.1007/s00277-021-04561-5

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Female
High-Throughput Nucleotide Sequencing
Humans
Janus Kinase 2 / genetics
Male
Middle Aged
Mutation
Myeloproliferative Disorders / diagnosis
Myeloproliferative Disorders / genetics*
Polycythemia Vera / diagnosis
Polycythemia Vera / genetics
Primary Myelofibrosis / diagnosis
Primary Myelofibrosis / genetics
Thrombocythemia, Essential / diagnosis
Thrombocythemia, Essential / genetics

Substances

JAK2 protein, human
Janus Kinase 2